Led by an interest in GLP-1 weight loss drugs, more health care brands may advertise in the Super Bowl this year.

The 63-year-old CEO of Life Time Fitness says people always want to know his workout and supplement prescription. Here's how ...

The convenience store segment faced economic challenges in 2024 with shifting consumer preferences, consolidation, inflation ...

For people with diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduced risk for certain disorders and conditions.

The international formula was designed to deliver all the benefits of the US formula while meeting regulatory requirements ...

The number of prescriptions for anti-obesity GLP-1 drugs like Wegovy and Ozempic is rising in North Carolina, just as it is nationwide — a trend that could have substantial effects on a range of ...

There are many ways to lose weight, but finding the best path can be difficult without assistance. The doctors at Ascension ...

Scouted selects products independently. If you purchase something from our posts, we may earn a small commission. Unless you ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Telehealth company's spot decries medications from others as "priced for profits, not patients," while its own weight-loss ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...